adaptive biotechnologies stock buy or sell

On a per-share basis the Seattle-based company said it. 03 2022 globe newswire -- adaptive biotechnologies corporation adaptive biotechnologies nasdaq.

Notable Adaptive Biotechnologies Insider Trades 460k In Company Stock

ADPT on Thursday reported a loss of 453 million in its third quarter.

. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before theyve reportedAdaptive Biotechnologies doesnt appear a compelling earnings. ADPT Stock Price Prediction 1350 11565 Upside Based on 4 Wall Street analysts offering 12 month price targets for Adaptive Biotechnologies in the last 3 months. 120 rows As of 2022 October 22 Saturday current price of ADPT stock is 6470 and our data.

The average Adaptive Biotechnologies stock price prediction forecasts a potential upside of 17157 from the current ADPT share price of 626. Engages in the development of an immune medicine platform. About ADPT Adaptive Biotechnologies Corp.

Published Jun 23 2021 1200PM EDT A daptive Biotechnologies ADPT could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank 2 Buy. The stock has a fifty day moving. Adaptive Biotechnologies appears a compelling earnings-beat candidate.

The stock has a market cap of 112 billion a. ADPT is owned by 9320 institutional shareholders 5930 Adaptive Biotechnologies insiders and 000 retail investors. Has a 12 month low of 595 and a 12 month high of 3755.

Adaptive Biotechnologies Corp ADPT stock is trading at 4818 as of 302 PM on Tuesday Sep 29 a loss of -019 or -039 from the previous closing price of 4837. You can buy or sell ADPT and other ETFs options and stocks. What is ADPTs Earnings Per Share EPS.

Adaptive Biotechnologies shares have declined 72 since the beginning of the year. Do Wall Street analysts like. It develops and commercializes immune-driven clinical products to transform the diagnosis and treatment of.

In the final minutes of trading on Thursday shares hit 778 a drop of 78 in the last 12. 9 hours agoSEATTLE AP _ Adaptive Biotechnologies Corp. Buy or sell Adaptive Biotechnologies stock pre IPO via an EquityZen fund EquityZen EquityZen is a marketplace for shares of proven pre IPO tech companies View More Companies 2019 IPO.

Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before theyve reported. Adaptive Biotechnologies Stock Rating What analysts recommend for ADPT stock on a scale from 1 buy to 5 sell. 12 2022 globe newswire -- adaptive biotechnologies corporation nasdaq.

Based on estimates by 9 analysts where scores have ranged from 100 for a strong buy to 500 for a strong sell 3 have rated the Adaptive Biotechnologies Corporation. Adpt a commercial stage biotechnology company that. 2022-09-12 083000 - Press Release.

According to the issued ratings of 8 analysts in the last year the consensus rating for Adaptive Biotechnologies stock is Moderate Buy based on the current 3 hold ratings and 5. Buy 56 Strong Buy 0 Buy 33 Hold 0 Sell 11 Strong. Adpt a commercial stage biotechnology company that.

Has a 1-year low of 595 and a 1-year high of 3755. Read on to find out how. Shares of ADPT opened at 785 on Thursday.

Learn more about whether Adaptive Biotechnologies Corp is a good stock to buy or sell based on recent news as well as its key financial metrics. 21 hours agoShares of ADPT opened at 785 on Thursday. Adaptive Biotechnologies Corporation is a commercial-stage biotech company.

The average twelve-month price prediction for Adaptive Biotechnologies is 2164 with a high price target of 5000 and a low price target of 750.

Earnings Outlook For Adaptive Biotechnologies Adaptive Biotechnologies Nasdaq Adpt Benzinga

Adaptive Biotechnologies Corporation Adpt Stock Price News Info The Motley Fool

Arkg Holdings Of Adaptive Biotechnologies Adpt Updated Daily

Adaptive Biotechnologies Stock Soars 90 After Ringing Nasdaq Opening Bell Following 300m Ipo Geekwire

Is Adaptive Biotechnologies A Buy The Motley Fool

Powering The Age Of Immune Medicine Adaptive Biotech

Adaptive Biotechnologies Corporation Adpt Stock Price Quote News Stock Analysis

Adaptive Biotechnologies Becomes Oversold Adpt Nasdaq

Adpt Adaptive Biotechnologies Full Company Report Zacks Com

We Re Not Very Worried About Adaptive Biotechnologies Nasdaq Adpt Cash Burn Rate

Adaptive Biotechnologies Corporation Adpt Stock Price Quote News Stock Analysis

Adpt Adaptive Biotechnologies Corp Stock Overview U S Nasdaq Barron S

Adaptive Biotechnologies Adpt Investor Presentation Slideshow Nasdaq Adpt Seeking Alpha

Adaptive Biotechnologies Goes Public In 300m Offering Puget Sound Business Journal

Adaptive Biotechnologies And Microsoft Launch Virtual Immunerace Study To Inform Novel Covid 19 Diagnostics To Address Unmet Needs In Testing Adaptive Biotechnologies

Insiders Probably Made The Right Decision Selling Us 557k Worth Of Shares Earlier This Year As Adaptive Biotechnologies Corporation S Nasdaq Adpt Stock Dips By 8 2 Nasdaq